Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 31.02%27.64B | -1.69%21.1B | 13.01%5.86B | -12.00%5.29B | 4.87%5.12B | -10.30%4.83B | 14.64%21.46B | 11.80%5.19B | 4.62%6.01B | 12.97%4.88B |
| Cost of revenue | 46.45%10.86B | -6.37%7.42B | 34.12%2.34B | -22.78%1.75B | 3.47%1.67B | -27.83%1.66B | 20.49%7.92B | 13.00%1.74B | 7.78%2.27B | 9.04%1.61B |
| Gross profit | 22.65%16.78B | 1.04%13.68B | 2.31%3.52B | -5.47%3.54B | 5.56%3.45B | 2.74%3.17B | 11.48%13.54B | 11.19%3.44B | 2.79%3.74B | 15.02%3.27B |
| Operating expense | 19.16%12.89B | 5.68%10.82B | 6.17%2.83B | 7.89%2.82B | 0.42%2.49B | 8.08%2.68B | 8.35%10.24B | 13.30%2.67B | 0.45%2.62B | 13.64%2.48B |
| Operating profit | 35.81%3.89B | -13.32%2.86B | -10.92%691.7M | -36.40%717.97M | 21.63%964.38M | -19.13%490.31M | 22.42%3.3B | 4.51%776.51M | 8.67%1.13B | 19.54%792.86M |
| Net non-operating interest income (expenses) | -97.22%-237.72M | -102.31%-120.53M | -66.11%-31.06M | -152.94%-33.5M | -113.32%-33.17M | -88.63%-22.8M | -25.99%-59.58M | -55.07%-18.7M | -19.34%-13.25M | -28.95%-15.55M |
| Non-operating interest income | -55.88%3.13M | -29.56%7.09M | -43.96%1.32M | -45.40%1.46M | -22.16%1.95M | -6.92%2.37M | -5.41%10.06M | -9.75%2.35M | 2.66%2.67M | -6.16%2.5M |
| Non-operating interest expense | 88.72%240.84M | 83.26%127.62M | 53.82%32.37M | 119.72%34.96M | 94.55%35.12M | 72.02%25.17M | 20.23%69.64M | 43.55%21.05M | 16.18%15.91M | 22.60%18.05M |
| Net investment income | -123.85%-37.49M | 27.73%157.23M | 1,147.97%89.42M | 28.87%-75.17M | 59.26%45.1M | -49.36%97.88M | -60.55%123.1M | -94.34%7.17M | -200.70%-105.69M | 28.32M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 103.57%6.4M | -836.47%-179.44M | -3,357.52%-4.98M | -19.16M | 153K | -400K | ||||
| Income from associates and other participating interests | 8.38M | 0 | ||||||||
| Special income (charges) | 76.23%-63.29M | 39.14%-266.21M | -19.81%-176.23M | 98.86%-3.14M | -538.72%-80.98M | -201.34%-5.85M | 44.21%-437.38M | 81.88%-147.1M | -833.85%-275.67M | 72.55%-12.68M |
| Less:Restructuring and mergern&acquisition | --76.25M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | -14,639.83%-344.91M | -100.94%-2.34M | -2,800.49%-5.48M | ---- | ---- | ---- | 695.43%250.1M | -89.67%203K | ---- | ---- |
| Less:Write off | 23.61%331.96M | 43.39%268.55M | 23.70%181.72M | --0 | 538.72%80.98M | 201.34%5.85M | -77.33%187.28M | -81.86%146.9M | 249.67%25.76M | 178.11%12.68M |
| Other non-operating income (expenses) | -409.99%-43.31M | 260.10%13.97M | 146.21%4.59M | 384.71%3.15M | -59.56%3.18M | -56.55%3.06M | -88.38%3.88M | -912.03%-9.92M | -114.05%-1.11M | -58.40%7.87M |
| Income before tax | 42.67%3.52B | -15.30%2.47B | -5.70%573.43M | -40.66%434.84M | 14.91%898.51M | -29.02%562.6M | 31.70%2.92B | 1,187.84%608.11M | -37.80%732.76M | 11.01%781.9M |
| Income tax | 15.08%1.55B | 14.65%1.34B | 125.97%383.66M | -29.09%262.15M | 19.77%403.01M | -0.35%295.3M | 67.33%1.17B | 173.51%169.79M | -17.12%369.71M | 32.79%336.49M |
| Net income | 75.63%1.98B | -35.44%1.13B | -56.70%189.77M | -52.43%172.7M | 11.25%495.5M | -46.14%267.3M | 15.21%1.74B | 57.56%438.32M | -50.40%363.05M | -1.23%445.41M |
| Net income continuous operations | 75.63%1.98B | -35.44%1.13B | -56.70%189.77M | -52.43%172.7M | 11.25%495.5M | -46.14%267.3M | 15.21%1.74B | 57.56%438.32M | -50.40%363.05M | -1.23%445.41M |
| Noncontrolling interests | -121.68%-8.52M | 149.95%39.29M | -731.50%-3.91M | 2,507.83%4.33M | 108.38%32.6M | 978.54%6.26M | -53.21%15.72M | 110.45%619K | -99.58%166K | 15.65M |
| Net income attributable to the company | 82.77%1.98B | -37.13%1.09B | -55.75%193.68M | -53.60%168.37M | 7.71%462.9M | -47.48%261.04M | 16.76%1.73B | 54.06%437.7M | -47.60%362.89M | -4.70%429.76M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 82.77%1.98B | -37.13%1.09B | -55.75%193.68M | -53.60%168.37M | 7.71%462.9M | -47.48%261.04M | 16.76%1.73B | 54.06%437.7M | -47.60%362.89M | -4.70%429.76M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 77.42%125.38 | -36.08%70.67 | -55.68%12.61 | -53.74%10.95 | 10.45%30.12 | -45.49%16.99 | 18.68%110.56 | 59.92%28.45 | -45.69%23.67 | -4.32%27.27 |
| Diluted earnings per share | 77.42%125.38 | -36.08%70.67 | -55.70%12.6038 | -53.62%10.95 | 10.45%30.12 | -45.49%16.99 | 18.68%110.56 | 59.92%28.45 | -45.82%23.61 | -4.32%27.27 |
| Dividend per share | -85.71%10 | 0.00%70 | 0.00%70 | 0 | 0 | 0 | 0.00%70 | 0.00%70 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |